Loading
Life sciences · Interventional Study
ClinicalTrials.gov · November 4, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07915427). This is a study registration, not published results. Lead sponsor: Gadjah Mada University. Recruitment status: ACTIVE_NOT_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 72 participants (ESTIMATED). Conditions: Depression. Interventions: BEHAVIORAL: HERDA Pharmacist-Led Culturally Adapted Intervention. Primary outcome measures: Medication Adherence Measured by MARS-5 , Day 0 (baseline), Day 30, Day 60, and Day 120.; Medication Adherence Measured by Pill Count , Day 0 (baseline), Day 30, Day 60, and Day 120.. Brief summary: HERDA (Holistic, Evidence-based, and cultuRally adapted Depression Adherence) is a pharmacist-led intervention developed to support medication adherence among outpatients with depression in South Kalimantan, Indonesia. It combines structured counseling, behavior change strategies, pharmaceutical care, and culturally adapted educational materials to help patients identify and address difficulties in taking their prescribed medication. The intervention incorporates the 5A Brief Counseling framework and the Transtheoretical Model (TTM), which guides counseling according to each participant's readiness to change. It also includes screening and a predefined safety pathway for suicide-related concerns, culturally adapted psychoeducation, and family or caregiver engagement when appropriate and with the participant's consent. Cultural, spiritual, and existential considerations are addressed according to individual preferences and within predefined intervention guidelines. HERDA is delivered by trained pharmacists alongside standard psychiatric care. Participants assigned to the intervention group receive seven planned contacts over approximately four months, combining face-to-face sessions and telephone contacts. Participants assigned to the control group receive standard psychiatric care according to the study protocol. This randomized controlled trial evaluates whether adding HERDA to standard psychiatric care improves medication adherence among outpatients with depression. The findings are intended to inform the development of evidence-based, culturally responsive pharmacist-led care for people receiving treatment for depression.